Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
Mohammad Rafieetary, OD, FAAO
Advertisement
Articles by Mohammad Rafieetary, OD, FAAO
Advertisement
Latest Updated Articles
A new era for MacTel: Clinicians react to FDA approval of revakinagene taroretcel-lweyPublished: March 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Avisi Technologies’ investigational device exemption for VisiPlate approved by FDA
2
FDA approves Rayner’s RayOne EMV Toric intraocular lens
3
Ophthalmic innovation by the decades: The 2000s
4
EyePoint Pharmaceuticals details phase 3 program evaluating vorolanib intravitreal insert (DURAVYU) for DME
5
.png "Optometry Times"){kind=logo}
